AIM
SIOX

Assured Investment Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Assured Investment Management’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-6,957
Closed -$74K – 1366
2018
Q1 		$74K Buy
+6,957
New +$112K ﹤0.01% 1073
2017
Q1 		– Sell
-9,163
Closed -$910K – 752
2016
Q4 		$910K Buy
9,163
+2,415
+36% +$254K 0.02% 341
2016
Q3 		$756K Buy
+6,748
New +$810K 0.02% 358

Other funds holding SIOX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Assured Investment Management's SIOX Position: Q2 2018 in Review

Assured Investment Management sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q2 2018, closing a stake of 6,957 shares — an estimated $74K sold.

Assured Investment Management first reported a position in SIOX in Q3 2016 and held it in 3 quarters. The position peaked at $910K in Q4 2016. 71 funds tracked by Wall St. Rank hold SIOX as of Q2 2018.

  • Assured Investment Management reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Assured Investment Management sold 6,957 Sio Gene Therapies Inc. Common Stock shares in Q2 2018, an estimated $74K.
  • Assured Investment Management first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2016 and held it in 3 quarters.
  • Assured Investment Management's Sio Gene Therapies Inc. Common Stock position peaked at $910K in Q4 2016.
  • 71 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q2 2018.

Based on Assured Investment Management's 13F filing for Q2 2018, filed 13 Aug 2018.